Mid-weight oncology stocks: The dark horses of cancer research
18 No. of Symbols
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−12.97 MXN
−1.64 B MXN
13.77 B MXN
126.92 M
About NeoGenomics, Inc.
Sector
Industry
CEO
Christopher Michael Smith
Website
Headquarters
Fort Myers
Founded
1998
FIGI
BBG00PPX0G26
NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
NEO5107997
NeoGenomics, Inc. 0.25% 15-JAN-2028Yield to maturity
5.62%
Maturity date
Jan 15, 2028
NEO4983005
NeoGenomics, Inc. 1.25% 01-MAY-2025Yield to maturity
4.94%
Maturity date
May 1, 2025
See all NEO bonds
Curated watchlists where NEO is featured.
Frequently Asked Questions
The current price of NEO is 200.00 MXN — it has decreased by −41.18% in the past 24 hours. Watch NEOGENOMICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange NEOGENOMICS INC stocks are traded under the ticker NEO.
NEO stock has fallen by −41.18% compared to the previous week, the month change is a −41.18% fall, over the last year NEOGENOMICS INC has showed a 0.76% increase.
We've gathered analysts' opinions on NEOGENOMICS INC future price: according to them, NEO price has a max estimate of 532.74 MXN and a min estimate of 307.35 MXN. Watch NEO chart and read a more detailed NEOGENOMICS INC stock forecast: see what analysts think of NEOGENOMICS INC and suggest that you do with its stocks.
NEO stock is 70.00% volatile and has beta coefficient of 1.38. Track NEOGENOMICS INC stock price on the chart and check out the list of the most volatile stocks — is NEOGENOMICS INC there?
Today NEOGENOMICS INC has the market capitalization of 27.50 B, it has decreased by −11.16% over the last week.
Yes, you can track NEOGENOMICS INC financials in yearly and quarterly reports right on TradingView.
NEOGENOMICS INC is going to release the next earnings report on May 6, 2025. Keep track of upcoming events with our Earnings Calendar.
NEO earnings for the last quarter are 0.83 MXN per share, whereas the estimation was 0.60 MXN resulting in a 38.73% surprise. The estimated earnings for the next quarter are −0.15 MXN per share. See more details about NEOGENOMICS INC earnings.
NEOGENOMICS INC revenue for the last quarter amounts to 3.59 B MXN, despite the estimated figure of 3.61 B MXN. In the next quarter, revenue is expected to reach 3.49 B MXN.
NEO net income for the last quarter is −319.50 M MXN, while the quarter before that showed −348.74 M MXN of net income which accounts for 8.38% change. Track more NEOGENOMICS INC financial stats to get the full picture.
No, NEO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 7, 2025, the company has 2.20 K employees. See our rating of the largest employees — is NEOGENOMICS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NEOGENOMICS INC EBITDA is −239.85 M MXN, and current EBITDA margin is 0.13%. See more stats in NEOGENOMICS INC financial statements.
Like other stocks, NEO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEOGENOMICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NEOGENOMICS INC technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NEOGENOMICS INC stock shows the strong sell signal. See more of NEOGENOMICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.